Cigna Group stock has delivered a 53.0% total return over the past five years, yet current valuation checks suggest the market may still be pricing it on the low side rather than at a clear premium. With the company reporting solid recent operations and pushing further into AI enabled healthcare support, investors are weighing whether the current share price fully reflects that profile.

• A 53.0% return over five years indicates Cigna Group has rewarded patient shareholders, which raises the question of how much value remains in the current price.
• Expansion of AI driven care management programs can support expectations for future profitability, while any pressure on healthcare costs or margins may limit how much investors are willing to pay for the stock.
• Cigna Group screens as undervalued on most checks, with a high value score of 5 out of 6. As a result, the broader indicators lean toward the shares still being priced below what its fundamentals may justify.

The issue now is whether Cigna Group's current valuation already reflects its recent progress and AI initiatives or if there is still a meaningful discount in the market price.

Is Cigna Group Still Cheap on Earnings?

The P/E ratio is a useful way to see how the market prices Cigna Group's earnings compared with other healthcare stocks. Cigna Group currently trades on a P/E of 12.1x, which is far below the broader healthcare industry average of 25.7x and also below the peer group average of 46.6x.

On Simply Wall St's tailored fair P/E estimate of 28.3x, which takes into account factors such as the company's sector, profitability profile and risk, the current multiple implies a sizeable discount. Despite the raised 2026 outlook following the strong second quarter update, the market is still valuing each dollar of Cigna Group earnings at a level that appears conservative compared with both sector norms and this fair value yardstick.

On the P/E multiple, Cigna Group stock appears undervalued relative to both its fair ratio and typical healthcare peers.

The Cigna Group Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Cigna Group pick up where this valuation puzzle leaves off by spelling out which paths for Cigna Group's growth, margins and earnings would need to hold for the stock to be worth materially more or less than today's price, based on community written scenarios that sit on the company's Community page. Rather than rely on a single multiple or model output, each narrative lays out the assumptions behind its view of fair value so you can compare those to actual results over time.

Be one of the first voices in the Simply Wall St community to set out a number driven view on whether Cigna Group's stronger 2026 outlook and expanded AI enabled care programs are fully reflected in the current share price. Share your narrative on Cigna Group's earnings power and see how your case holds up as new results and product updates come through.

Do you think there's more to the story for Cigna Group? Head over to our Community to see what others are saying!

The Bottom Line

Cigna Group still screens as undervalued on market multiples, so the current price looks more conservative than many peers relative to its earnings. The broader valuation checks lean in the same direction, which gives that signal more weight than a single ratio in isolation. The real question from here is whether Cigna Group can sustain the earnings profile that justifies a higher multiple, or if concerns around healthcare costs and the execution of its AI enabled programs keep the discount in place.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.